Adverse events57

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 57

Type	Event	Organ system	Group	Affected	At risk	Events
other	Covid-19	Infections and infestations	Tusamitamab Ravtansine + Ramucirumab	3	35	3
other	Gastroenteritis	Infections and infestations	Tusamitamab Ravtansine + Ramucirumab	2	35	2
other	Upper Respiratory Tract Infection	Infections and infestations	Tusamitamab Ravtansine + Ramucirumab	2	35	2
other	Anaemia	Blood and lymphatic system disorders	Tusamitamab Ravtansine + Ramucirumab	6	35	7
other	Neutropenia	Blood and lymphatic system disorders	Tusamitamab Ravtansine + Ramucirumab	5	35	12
other	Thrombocytopenia	Blood and lymphatic system disorders	Tusamitamab Ravtansine + Ramucirumab	5	35	11
other	Decreased Appetite	Metabolism and nutrition disorders	Tusamitamab Ravtansine + Ramucirumab	8	35	8
other	Dysgeusia	Nervous system disorders	Tusamitamab Ravtansine + Ramucirumab	3	35	3
other	Headache	Nervous system disorders	Tusamitamab Ravtansine + Ramucirumab	3	35	3
other	Peripheral Sensory Neuropathy	Nervous system disorders	Tusamitamab Ravtansine + Ramucirumab	3	35	3
other	Keratitis	Eye disorders	Tusamitamab Ravtansine + Ramucirumab	3	35	4
other	Keratopathy	Eye disorders	Tusamitamab Ravtansine + Ramucirumab	8	35	13
other	Vision Blurred	Eye disorders	Tusamitamab Ravtansine + Ramucirumab	3	35	3
other	Hypertension	Vascular disorders	Tusamitamab Ravtansine + Ramucirumab	10	35	15
other	Hypotension	Vascular disorders	Tusamitamab Ravtansine + Ramucirumab	2	35	2
other	Dysphonia	Respiratory, thoracic and mediastinal disorders	Tusamitamab Ravtansine + Ramucirumab	3	35	3
other	Dyspnoea	Respiratory, thoracic and mediastinal disorders	Tusamitamab Ravtansine + Ramucirumab	2	35	2
other	Epistaxis	Respiratory, thoracic and mediastinal disorders	Tusamitamab Ravtansine + Ramucirumab	2	35	2
other	Ascites	Gastrointestinal disorders	Tusamitamab Ravtansine + Ramucirumab	2	35	2
other	Constipation	Gastrointestinal disorders	Tusamitamab Ravtansine + Ramucirumab	4	35	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05071053/events

API reference For AI assistants

Adverse events57

Sources 3

Read this list from software.